Tokyo, Japan

Shunji Hayasaka

This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignees: Somar Corporation, The University of Tokyo. Active years: 2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Shunji Hayasaka. Retrieved from https://idiyas.com/inventor/shunji-hayasaka

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0


Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Shunji Hayasaka: Innovator in Cell Culture Technology

Introduction

Shunji Hayasaka is a prominent inventor based in Tokyo, Japan. He is known for his significant contributions to the field of cell culture technology. His innovative methods have the potential to advance research and applications in biotechnology and medicine.

Latest Patents

Hayasaka holds a patent for a cell culture method, which includes cell aggregates, a cell aggregation control agent, and a medium. This method allows for the control of the diameter of cell aggregates, enabling the production of a large quantity of cells. The patent describes a suspension culture method that incorporates an aggregation control step, where a substance is added to inhibit cell adhesion molecules, thereby controlling cell aggregation.

Career Highlights

Throughout his career, Shunji Hayasaka has worked with notable organizations, including Somar Corporation and The University of Tokyo. His work has focused on enhancing cell culture techniques, which are crucial for various applications in research and industry.

Collaborations

Hayasaka has collaborated with esteemed colleagues such as Yasuyuki Sakai and Ikki Horiguchi. These partnerships have contributed to the advancement of his research and the development of innovative solutions in cell culture.

Conclusion

Shunji Hayasaka's contributions to cell culture technology exemplify the impact of innovation in the field of biotechnology. His patented methods are paving the way for future advancements in cell research and applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…